Copyright Reports & Markets. All rights reserved.

Global Angiotensin Receptor Blockers (ARBs) Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Angiotensin Receptor Blockers (ARBs) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Angiotensin Receptor Blockers (ARBs) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size Growth Rate by Type
    • 1.4.2 Valsartan
    • 1.4.3 Telmisartan
    • 1.4.4 Losartan
    • 1.4.5 Irbesartan
    • 1.4.6 Azilsartan
    • 1.4.7 Olmesartan
  • 1.5 Market by Application
    • 1.5.1 Global Angiotensin Receptor Blockers (ARBs) Market Size Growth Rate by Application
    • 1.5.2 Hypertension
    • 1.5.3 Cardiovascular Diseases
    • 1.5.4 Kidney Diseases
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Angiotensin Receptor Blockers (ARBs) Market Size, Estimates and Forecasts
    • 2.1.1 Global Angiotensin Receptor Blockers (ARBs) Revenue 2015-2026
    • 2.1.2 Global Angiotensin Receptor Blockers (ARBs) Sales 2015-2026
  • 2.2 Global Angiotensin Receptor Blockers (ARBs), Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Angiotensin Receptor Blockers (ARBs) Competitor Landscape by Players

  • 3.1 Angiotensin Receptor Blockers (ARBs) Sales by Manufacturers
    • 3.1.1 Angiotensin Receptor Blockers (ARBs) Sales by Manufacturers (2015-2020)
    • 3.1.2 Angiotensin Receptor Blockers (ARBs) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturers
    • 3.2.1 Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Angiotensin Receptor Blockers (ARBs) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Angiotensin Receptor Blockers (ARBs) Revenue in 2019
    • 3.2.5 Global Angiotensin Receptor Blockers (ARBs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Angiotensin Receptor Blockers (ARBs) Price by Manufacturers
  • 3.4 Angiotensin Receptor Blockers (ARBs) Manufacturing Base Distribution, Product Types
    • 3.4.1 Angiotensin Receptor Blockers (ARBs) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Angiotensin Receptor Blockers (ARBs) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Angiotensin Receptor Blockers (ARBs) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Type (2015-2020)
    • 4.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales by Type (2015-2020)
    • 4.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Type (2015-2020)
    • 4.1.3 Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Angiotensin Receptor Blockers (ARBs) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Application (2015-2020)
    • 5.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales by Application (2015-2020)
    • 5.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Application (2015-2020)
    • 5.1.3 Angiotensin Receptor Blockers (ARBs) Price by Application (2015-2020)
  • 5.2 Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Angiotensin Receptor Blockers (ARBs) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Angiotensin Receptor Blockers (ARBs) by Country
    • 6.1.1 North America Angiotensin Receptor Blockers (ARBs) Sales by Country
    • 6.1.2 North America Angiotensin Receptor Blockers (ARBs) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Type
  • 6.3 North America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Angiotensin Receptor Blockers (ARBs) by Country
    • 7.1.1 Europe Angiotensin Receptor Blockers (ARBs) Sales by Country
    • 7.1.2 Europe Angiotensin Receptor Blockers (ARBs) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Type
  • 7.3 Europe Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Angiotensin Receptor Blockers (ARBs) by Region
    • 8.1.1 Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales by Region
    • 8.1.2 Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Type
  • 8.3 Asia Pacific Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Angiotensin Receptor Blockers (ARBs) by Country
    • 9.1.1 Latin America Angiotensin Receptor Blockers (ARBs) Sales by Country
    • 9.1.2 Latin America Angiotensin Receptor Blockers (ARBs) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Type
  • 9.3 Central & South America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Angiotensin Receptor Blockers (ARBs) by Country
    • 10.1.1 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales by Country
    • 10.1.2 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description and Business Overview
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.2.5 Novartis Related Developments
  • 11.3 Merck
    • 11.3.1 Merck Corporation Information
    • 11.3.2 Merck Description and Business Overview
    • 11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merck Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.3.5 Merck Related Developments
  • 11.4 Astra Zeneca
    • 11.4.1 Astra Zeneca Corporation Information
    • 11.4.2 Astra Zeneca Description and Business Overview
    • 11.4.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.4.5 Astra Zeneca Related Developments
  • 11.5 Jhonson and Johnson
    • 11.5.1 Jhonson and Johnson Corporation Information
    • 11.5.2 Jhonson and Johnson Description and Business Overview
    • 11.5.3 Jhonson and Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.5.5 Jhonson and Johnson Related Developments
  • 11.6 Eli Lilly
    • 11.6.1 Eli Lilly Corporation Information
    • 11.6.2 Eli Lilly Description and Business Overview
    • 11.6.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Eli Lilly Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.6.5 Eli Lilly Related Developments
  • 11.7 Sanofi
    • 11.7.1 Sanofi Corporation Information
    • 11.7.2 Sanofi Description and Business Overview
    • 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sanofi Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.7.5 Sanofi Related Developments
  • 11.8 Bristol-Myers Squibb
    • 11.8.1 Bristol-Myers Squibb Corporation Information
    • 11.8.2 Bristol-Myers Squibb Description and Business Overview
    • 11.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.8.5 Bristol-Myers Squibb Related Developments
  • 11.9 Bayer
    • 11.9.1 Bayer Corporation Information
    • 11.9.2 Bayer Description and Business Overview
    • 11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Bayer Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.9.5 Bayer Related Developments
  • 11.10 GSK
    • 11.10.1 GSK Corporation Information
    • 11.10.2 GSK Description and Business Overview
    • 11.10.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 GSK Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.10.5 GSK Related Developments
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Angiotensin Receptor Blockers (ARBs) Products Offered
    • 11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Angiotensin Receptor Blockers (ARBs) Market Estimates and Projections by Region
    • 12.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Angiotensin Receptor Blockers (ARBs) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Angiotensin Receptor Blockers (ARBs) Sales Forecast (2021-2026)
    • 12.2.2 North America: Angiotensin Receptor Blockers (ARBs) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Angiotensin Receptor Blockers (ARBs) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Angiotensin Receptor Blockers (ARBs) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Angiotensin Receptor Blockers (ARBs) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Angiotensin Receptor Blockers (ARBs) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Angiotensin Receptor Blockers (ARBs) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Angiotensin Receptor Blockers (ARBs) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Angiotensin Receptor Blockers (ARBs) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Angiotensin Receptor Blockers (ARBs) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Angiotensin Receptor Blockers (ARBs) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Angiotensin Receptor Blockers (ARBs) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Angiotensin Receptor Blockers (ARBs) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Angiotensin Receptor Blockers (ARBs) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Angiotensin Receptor Blockers (ARBs) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Angiotensin Receptor Blockers (ARBs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin Receptor Blockers (ARBs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Angiotensin Receptor Blockers (ARBs) market is segmented into
    Valsartan
    Telmisartan
    Losartan
    Irbesartan
    Azilsartan
    Olmesartan

    Segment by Application, the Angiotensin Receptor Blockers (ARBs) market is segmented into
    Hypertension
    Cardiovascular Diseases
    Kidney Diseases
    Other

    Regional and Country-level Analysis
    The Angiotensin Receptor Blockers (ARBs) market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Angiotensin Receptor Blockers (ARBs) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Angiotensin Receptor Blockers (ARBs) Market Share Analysis
    Angiotensin Receptor Blockers (ARBs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiotensin Receptor Blockers (ARBs) business, the date to enter into the Angiotensin Receptor Blockers (ARBs) market, Angiotensin Receptor Blockers (ARBs) product introduction, recent developments, etc.

    The major vendors covered:
    Pfizer
    Novartis
    Merck
    Astra Zeneca
    Jhonson and Johnson
    Eli Lilly
    Sanofi
    Bristol-Myers Squibb
    Bayer
    GSK
    Teva Pharmaceutical

    Buy now